En cliquant sur ce lien, vous quittez le site Aguettant.fr Si vous accédez à l’un des sites internet du Groupe AGUETTANT, sachez que les réglementations et les pratiques médicales peuvent varier d’un pays à l’autre. En conséquence, les informations délivrées sur ce site peuvent ne pas être appropriées pour une utilisation en France.



At Aguettant, improvements in safety of medical practices, is driven by innovation with focus on prevention of medication errors in particular.


Laboratoire Aguettant understands the complexity of providing safe medicine for patients, due to the diversity of pathologies and their degree of urgency. We strive to develop innovative, Ready To Use and Ready To Administer solutions, designed to prevent medication errors.

The innovation process puts healthcare professionals and their patients at the heart of our approach. Our products are regularly discussed with experts from the different therapeutic fields covered by Aguettant.

By developing innovative products, the goal is to minimise risks for patients and healthcare professionals.

Our goal: Collaborating with healthcare professionals and international experts, our goal is to improve the safety of medical practices.


R&D is the core of Laboratoire Aguettants innovation strategy and a key element in the competitiveness of the company.

Aguettant has, throughout its entire historry, combined pharmaceutical and technological knowledge to focus on improvement of patient care and making procedures easier and safer for medical staff.

Our R&D teams work on perfecting new formulations, especially in the field of injectable medicines, aiming to deliver better and more effective patient care. 

Learn more about our R&D department


Optimised processes technological innovation are leading to high-performance production sites. Aguettant´s production cycle operates at the highest standard to maintain consistent production of quality products.

Aguettant has a comprehensive quality management system, created to ensure the quality of our products.

The Aguettant manufacturing sites produce every year  more than100 MILLION MEDICINE UNITS distributed in more than 70 countries.

Laboratoire Aguettant has brad expertise within injectable medicines. The pharmaceutical forms are:
•    Syringe
•    Pen
•    Vial
•    Glass ampoule
•    Plastic ampoule
•    Irrigation fluids in bags & bottles